Mertz Leslie
IEEE Pulse. 2012 Sep-Oct;3(5):10-6. doi: 10.1109/MPUL.2012.2208024.
The first visual prosthetic is on the commercial stage now, and a variety of new retinal and cortical implants are in the wings. When it won the European stamp of approval last year, the Argus II became the first commercially available visual prosthesis. Now Second Sight Medical Products Inc. of Sylmar, California, the company behind the Argus II, hopes to receive approval to sell the device in the United States by late 2012. As the excitement over the Argus II continues at a fever pitch, other research groups are developing their own versions of visual prostheses, working to create the potential for restoring sight.
首款视觉假体现已进入商业阶段，各种新型视网膜和皮层植入物也即将问世。去年获得欧洲批准后，阿格斯二代成为首款可商业化的视觉假体。位于加利福尼亚州西尔玛市的第二视觉医疗产品公司是阿格斯二代背后的企业，该公司希望在2012年底前获得在美国销售该设备的批准。在对阿格斯二代的兴奋之情持续高涨之际，其他研究团队也在开发自己的视觉假体版本，努力创造恢复视力的可能性。
